Literature DB >> 7259350

Reduction in alternative complement pathway mediated C3 conversion following burn injury.

A B Bjornson, H S Bjornson, W A Altemeier.   

Abstract

Studies were performed to further investigate an abnormality of the alternative complement pathway associated with burn injury. C3 conversion by inulin and cobra venom factor was measured in serial serum samples from 18 burned patients and in the sera from 25 normal controls. C3 conversion by both activating substances in the patients' sera was significantly decreased during 50 days postburn in comparison to C3 conversion in the normal sera. The most marked reduction in C3 conversion occurred in patients with large full-thickness injuries and infectious complications. However, the abnormality was not more severe in patients with pneumonia and bacteremia in comparison to patients with bacteremia only. It was also not predictive of fatal outcome resulting from infectious complications. Preliminary evidence was presented to suggest that the abnormality is caused by a serum inhibitor, which has an affinity for cellulose and/or is inactivated by it.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7259350      PMCID: PMC1345244          DOI: 10.1097/00000658-198108000-00018

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  35 in total

1.  Role of complement in induction of the allergic response.

Authors:  M B Pepys
Journal:  Nat New Biol       Date:  1972-05-31

2.  Antigenic determinants of human beta-1c and beta-1g-globulins.

Authors:  C West; N C Davis; J Forristal; J Herbst; R Spitzer
Journal:  J Immunol       Date:  1966-04       Impact factor: 5.422

3.  The C3-activator system: an alternate pathway of complement activation.

Authors:  O Götze; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1971-09-01       Impact factor: 14.307

4.  Alternate complement pathway: factors involved in cobra venom factor (CoVF) activation of the third component of complement (C3).

Authors:  L G Hunsicker; S Ruddy; K F Austen
Journal:  J Immunol       Date:  1973-01       Impact factor: 5.422

5.  Role of C3 in in vitro lymphocyte cooperation.

Authors:  M Feldmann; M B Pepys
Journal:  Nature       Date:  1974-05-10       Impact factor: 49.962

6.  Immunochemical quantitation of antigens by single radial immunodiffusion.

Authors:  G Mancini; A O Carbonara; J F Heremans
Journal:  Immunochemistry       Date:  1965-09

7.  Hypocomplementemia of membranoproliferative nephritis. Dependence of the nephritic factor reaction on properdin factor B.

Authors:  E J Ruley; J Forristal; N C Davis; C Andres; C D West
Journal:  J Clin Invest       Date:  1973-04       Impact factor: 14.808

8.  Formation of a hemolytically active cellular intermediate by the interaction between properdin factors B and D and the activated third component of complement.

Authors:  D T Fearon; K F Austen; S Ruddy
Journal:  J Exp Med       Date:  1973-12-01       Impact factor: 14.307

9.  Formation and function of a complex of the C3 proactivator with a protein from cobra venom.

Authors:  N R Cooper
Journal:  J Exp Med       Date:  1973-02-01       Impact factor: 14.307

10.  Role of complement in induction of antibody production in vivo. Effect of cobra factor and other C3-reactive agents on thymus-dependent and thymus-independent antibody responses.

Authors:  M B Pepys
Journal:  J Exp Med       Date:  1974-07-01       Impact factor: 14.307

View more
  6 in total

1.  Acute generalized microvascular injury by activated complement and hypoxia: the basis of the adult respiratory distress syndrome and multiple organ failure?

Authors:  J K Nuytinck; R J Goris; J G Weerts; P H Schillings; J H Stekhoven
Journal:  Br J Exp Pathol       Date:  1986-08

Review 2.  The immunologic response to thermal injury.

Authors:  M Heideman; A Bengtsson
Journal:  World J Surg       Date:  1992 Jan-Feb       Impact factor: 3.352

3.  Role of chemotactic factors in neutrophil activation after thermal injury in rats.

Authors:  M T Piccolo; Y Wang; S Verbrugge; R L Warner; P Sannomiya; N S Piccolo; M S Piccolo; T E Hugli; P A Ward; G O Till
Journal:  Inflammation       Date:  1999-08       Impact factor: 4.092

4.  Development and application of an enzyme-linked immunosorbent assay for the quantitation of alternative complement pathway activation in human serum.

Authors:  J T Mayes; R D Schreiber; N R Cooper
Journal:  J Clin Invest       Date:  1984-01       Impact factor: 14.808

5.  Serum-mediated inhibition of polymorphonuclear leukocyte function following burn injury.

Authors:  A B Bjornson; H S Bjornson; W A Altemeier
Journal:  Ann Surg       Date:  1981-11       Impact factor: 12.969

Review 6.  Bench-to-bedside review: Burn-induced cerebral inflammation--a neglected entity?

Authors:  Michael A Flierl; Philip F Stahel; Basel M Touban; Kathryn M Beauchamp; Steven J Morgan; Wade R Smith; Kyros R Ipaktchi
Journal:  Crit Care       Date:  2009-06-29       Impact factor: 9.097

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.